设计和对瘤病,病和曼索内洛症随机临床试验的分析:系统性审查
Fabrice Lotola Mougeni1, Marta Bofill Roig2, Marc P Hübner3,4
1Center for Medical Data Science, Medical University of Vienna, Vienna, Austria.
PLoS neglected tropical diseases
|February 20, 2026
概括
本综述强调了 filarial 疾病试验中的统计挑战,发现了设计和分析的显著异质性. 建议使用CONSORT和ICH E9 (R1) 准则进行改进的报告,以提高瘤病,病和曼索内洛症研究的透明度.
科学领域:
- 临床试验方法论 临床试验方法论
- 寄生性疾病 寄生性疾病
- 生物统计学 生物统计学
背景情况:
- 对于像科病,病和曼索内洛症这样的细菌性疾病的随机临床试验 (RCT) 面临统计上的障碍.
- 挑战包括倾斜的终点和小样本大小,使试验设计和分析复杂化.
研究的目的:
- 系统地审查RCT的设计和统计分析方法,以检测科病,病和曼索内洛症.
- 确定这些被忽视的热带疾病的试验方法的共同实践和改进领域.
主要方法:
- 系统地搜索PubMed和试验注册表 (2000-2024) 相关的RCT.
- 包含/排除标准侧重于治疗研究,不包括早期阶段或药理动力学试验.
- 从44项符合条件的研究的手稿,协议和注册表中提取数据.
主要成果:
- 瘤病试验主要使用了定性初级终点,而病和曼森氏病试验更经常使用定量终点.
- 曼 - 惠特尼U和奇平方测试是主要终点分析的常见方法.
- 在研究中的试验设计参数 (终点,随访,分析群体) 中观察到显著的异质性.
结论:
- 虽然一些试验报告得很好,但其他试验缺乏足够的细节,需要更结构化和透明的报告.
- 建议采用CONSORT和ICH E9 (R1) 的估计方法.
- 提高透明度将更好地使试验目标,分析和结论与 filarial 疾病研究相协调.
相关概念视频
Study Designs in Epidemiology
1.1K
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
1.1K
Clinical Trials
10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
10.9K
Bioequivalence Experimental Study Designs: Repeated Measures, Cross-Over, Carry-Over, and Latin Square Designs
266
Body:Bioequivalence experimental study designs play a pivotal role in testing the effectiveness of various treatments. Key among these are the repeated measures, cross-over, carry-over, and Latin square designs. In the repeated measures design, each subject receives all treatments, allowing for temporal comparisons. This type of design is useful in reducing variability but requires careful planning to avoid bias.The cross-over design, an economical method, involves sequential administration of...
266
Clinical Trials: Overview
5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
491
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
491
Dosage Regimens: Designs and Approaches
367
Designing a dosage regimen, which refers to the manner of drug administration, is a complex process involving the selection of drug dose, route, and frequency. This process is underpinned by pharmacokinetic parameters derived from tests and population averages. These parameters are then tailored to patient-specific variables such as diagnosis, demographics, and allergy status. Once therapy commences, therapeutic response monitoring is critical and achieved through clinical and physical...
367


